Korea Research Institute of Chemical Technology;Handok Inc.
发明人:
申请号:
EP13894061.4
公开号:
EP3053923A4
申请日:
2013.09.30
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention relates to a novel triazolopyrazine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating hyper proliferative disorder. The present invention can be useful as a therapeutic agent for various hyper proliferative disorders associated with excessive cell proliferation and growth caused by abnormal kinase activity, such as cancer, psoriasis, rheumatoid arthritis, and diabetic retinopathy, by efficiently inhibiting c-Met tyrosine kinase activity.